Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Foris (Graz, Austria), F. Prüller (Graz, Austria), G. Kovacs (Graz, Austria), A. Avian (Graz, Austria), P. Douschan (Graz, Austria), M. Herrmann (Graz, Austria), H. Olschewski (Graz, Austria). Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension. 1527

Member's Comments

No comment yet.

Related content which might interest you: emPHasis-10 score predicts mortality in patients with pulmonary hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018 Year: 2018 Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin Source: Eur Respir J 2015; 46: 1701-1710 Year: 2015 Arterial hypertension and the risk of severity and mortality of COVID-19 Source: Eur Respir J, 55 (6) 2001148; 10.1183/13993003.01148-2020 Year: 2020 Validation of a prognostic score for pulmonary embolism short-term mortality Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Non-invasive mortality predictors in pediatric pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018 External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension Source: ERJ Open Res, 8 (1) 00006-2022; 10.1183/23120541.00006-2022 Year: 2022 The signifigance of NT-proBNP value pulmonary tromboembolism in early mortality Source: Annual Congress 2006 - Pulmonary embolism Year: 2006 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018 Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017 Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009